Published in Hepatitis Weekly, May 5th, 2008
"To examine the viability of lamivudine and similar monotherapies as a treatment strategy in chronic HBV in the face of the worldwide...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.